Experimental studies show that after BrdU injection in mice brain following stroke, the BrdU labeled cells are first Dcx (immature neuron marker) immunoreactive for a few weeks, then gradually lose this expression and become NeuN (mature neuron marker) immunoreactive45,56. This evidence concerns the gene RBFOX3 and stroke disorder.